CN Patent

CN115551478A — 具有改善递送和血浆半衰期的罗氟司特局部制剂

Assigned to Alcutis Biotherapy Co ltd · Expires 2022-12-30 · 3y expired

What this patent protects

本发明涉及改善用罗氟司特治疗的治疗结果的方法。通过局部给药罗氟司特组合物的持续递送和/或更长的血浆半衰期来改善治疗结果。罗氟司特组合物优选包含磷酸二鲸蜡酯、鲸蜡醇聚醚‑10磷酸酯、二甘醇单乙醚，和/或己二醇。

USPTO Abstract

本发明涉及改善用罗氟司特治疗的治疗结果的方法。通过局部给药罗氟司特组合物的持续递送和/或更长的血浆半衰期来改善治疗结果。罗氟司特组合物优选包含磷酸二鲸蜡酯、鲸蜡醇聚醚‑10磷酸酯、二甘醇单乙醚，和/或己二醇。

Drugs covered by this patent

Patent Metadata

Patent number
CN115551478A
Jurisdiction
CN
Classification
—
Expires
2022-12-30
Drug substance claim
No
Drug product claim
No
Assignee
Alcutis Biotherapy Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.